Compile Data Set for Download or QSAR
maximum 50k data
Found 172 Enz. Inhib. hit(s) with all data for entry = 1000
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172430(US9090618, ZA53 | US9598411, Ref. No. ZA53)
Affinity DataKi:  0.800nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172419(US9090618, ZA42 | US9598411, Ref. No. ZA42)
Affinity DataKi:  0.920nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172418(US9090618, ZA41 | US9598411, Ref. No. ZA41)
Affinity DataKi:  1.15nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172382(US9090618, H27b(i) | US9598411, Ref. No. H27b(i))
Affinity DataKi:  1.90nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172433(US9090618, ZA56 | US9598411, Ref. No. ZA56)
Affinity DataKi:  2.05nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172417(US9090618, ZA40 | US9598411, Ref. No. ZA40)
Affinity DataKi:  2.20nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172413(US9090618, ZA35 | US9598411, Ref. No. ZA35)
Affinity DataKi:  2.68nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172438(US9090618, ZA61 | US9598411, Ref. No. ZA61)
Affinity DataKi:  3.80nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172440(US9090618, ZA63 | US9598411, Ref. No. ZA63)
Affinity DataKi:  4.11nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172444(US9090618, ZA67 | US9598411, Ref. No. ZA67)
Affinity DataKi:  4.20nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172437(US9090618, ZA60 | US9598411, Ref. No. ZA60)
Affinity DataKi:  4.5nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172380(US9090618, H4d | US9598411, Ref. No. H4d)
Affinity DataKi:  4.73nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172446(US9090618, ZA69 | US9598411, Ref. No. ZA69)
Affinity DataKi:  4.90nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172416(US9090618, ZA39 | US9598411, Ref. No. ZA39)
Affinity DataKi:  5.10nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172432(US9090618, ZA55 | US9598411, Ref. No. ZA55)
Affinity DataKi:  5.40nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172445(US9090618, ZA68 | US9598411, Ref. No. ZA68)
Affinity DataKi:  6nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172427(US9090618, ZA50 | US9598411, Ref. No. ZA50)
Affinity DataKi:  6.14nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172447(US9090618, ZA70 | US9598411, Ref. No. ZA70)
Affinity DataKi:  6.70nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172443(US9090618, ZA66 | US9598411, Ref. No. ZA66)
Affinity DataKi:  7.10nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172434(US9090618, ZA57 | US9598411, Ref. No. ZA57)
Affinity DataKi:  8.5nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172381(US9090618, H6d | US9598411, Ref. No. H6d)
Affinity DataKi:  8.90nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172384(US9090618, H30b(ii) | US9598411, Ref. No. H30b(ii))
Affinity DataKi:  9nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDelta-type opioid receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172408(US9090618, ZA27 | US9598411, Ref. No. ZA27)
Affinity DataKi:  10nMAssay Description:ORL-1 Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like receptor (ORL-1) (Recepto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMu-type opioid receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172390(US9090618, H56b(ii) | US9598411, Ref. No. H56b(ii))
Affinity DataKi:  11nMAssay Description:κ-Opioid Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human kappa opioid receptor (kappa) (cloned ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172426(US9090618, ZA49 | US9598411, Ref. No. ZA49)
Affinity DataKi:  11.5nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDelta-type opioid receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172412(US9090618, ZA33 | US9598411, Ref. No. ZA33)
Affinity DataKi:  13nMAssay Description:ORL-1 Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like receptor (ORL-1) (Recepto...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172397(US9090618, ZA09 | US9598411, Ref. No. ZA09)
Affinity DataKi:  14.2nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172420(US9090618, ZA43 | US9598411, Ref. No. ZA43)
Affinity DataKi:  14.9nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172393(US9090618, H62d(ii) | US9598411, Ref. No. H62d(ii))
Affinity DataKi:  15.7nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172429(US9090618, ZA52 | US9598411, Ref. No. ZA52)
Affinity DataKi:  15.8nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKappa-type opioid receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172390(US9090618, H56b(ii) | US9598411, Ref. No. H56b(ii))
Affinity DataKi:  16.3nMAssay Description:μ-Opioid Receptor Binding Assay Procedures: Radioligand binding assays were conducted using freshly thawed membranes expressing human μ-rec...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172423(US9090618, ZA46 | US9090618, ZA54 | US9598411, Ref...)
Affinity DataKi:  17nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172407(US9090618, ZA26 | US9598411, Ref. No. ZA26)
Affinity DataKi:  17.5nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172383(US9090618, H30b(i) | US9598411, Ref. No. H30b(i))
Affinity DataKi:  18.2nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172385(US9090618, H30d(ii) | US9598411, Ref. No. H30d(ii))
Affinity DataKi:  18.6nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172388(US9090618, H36b(i) | US9598411, Ref. No. H36b(i))
Affinity DataKi:  19nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172435(US9090618, ZA58 | US9598411, Ref. No. ZA58)
Affinity DataKi:  19.9nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172448(US9090618, ZA71 | US9598411, Ref. No. ZA71)
Affinity DataKi:  20.8nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172441(US9090618, ZA64 | US9598411, Ref. No. ZA64)
Affinity DataKi:  21.6nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172394(US9090618, O85d | US9598411, Ref. No. O85d)
Affinity DataKi:  21.7nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172409(US9090618, ZA28 | US9598411, Ref. No. ZA28)
Affinity DataKi:  22.4nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172398(US9090618, ZA10 | US9598411, Ref. No. ZA10)
Affinity DataKi:  23.5nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKappa-type opioid receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172409(US9090618, ZA28 | US9598411, Ref. No. ZA28)
Affinity DataKi:  26.2nMAssay Description:μ-Opioid Receptor Binding Assay Procedures: Radioligand binding assays were conducted using freshly thawed membranes expressing human μ-rec...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM302115(US9598411, Ref. No. ZA23)
Affinity DataKi:  27.7nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172436(US9090618, ZA59 | US9598411, Ref. No. ZA59)
Affinity DataKi:  29.5nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKappa-type opioid receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172429(US9090618, ZA52 | US9598411, Ref. No. ZA52)
Affinity DataKi:  30.4nMAssay Description:μ-Opioid Receptor Binding Assay Procedures: Radioligand binding assays were conducted using freshly thawed membranes expressing human μ-rec...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKappa-type opioid receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172432(US9090618, ZA55 | US9598411, Ref. No. ZA55)
Affinity DataKi:  31.3nMAssay Description:μ-Opioid Receptor Binding Assay Procedures: Radioligand binding assays were conducted using freshly thawed membranes expressing human μ-rec...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKappa-type opioid receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172408(US9090618, ZA27 | US9598411, Ref. No. ZA27)
Affinity DataKi:  33.7nMAssay Description:μ-Opioid Receptor Binding Assay Procedures: Radioligand binding assays were conducted using freshly thawed membranes expressing human μ-rec...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172425(US9090618, ZA48 | US9598411, Ref. No. ZA48)
Affinity DataKi:  36nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNociceptin receptor(Homo sapiens (Human))
Purdue Pharma

US Patent
LigandPNGBDBM172408(US9090618, ZA27 | US9598411, Ref. No. ZA27)
Affinity DataKi:  36.7nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 172 total ) | Next | Last >>
Jump to: